324 related articles for article (PubMed ID: 16809010)
1. Combination strategies for enhancing transdermal absorption of sumatriptan through skin.
Femenía-Font A; Balaguer-Fernández C; Merino V; López-Castellano A
Int J Pharm; 2006 Oct; 323(1-2):125-30. PubMed ID: 16809010
[TBL] [Abstract][Full Text] [Related]
2. Effect of chemical enhancers on the in vitro percutaneous absorption of sumatriptan succinate.
Femenía-Font A; Balaguer-Fernández C; Merino V; Rodilla V; López-Castellano A
Eur J Pharm Biopharm; 2005 Sep; 61(1-2):50-5. PubMed ID: 15925502
[TBL] [Abstract][Full Text] [Related]
3. Effect of DC/mDC iontophoresis and terpenes on transdermal permeation of methotrexate: in vitro study.
Prasad R; Koul V; Anand S; Khar RK
Int J Pharm; 2007 Mar; 333(1-2):70-8. PubMed ID: 17116378
[TBL] [Abstract][Full Text] [Related]
4. Enhanced iontophoretic delivery of buspirone hydrochloride across human skin using chemical enhancers.
Meidan VM; Al-Khalili M; Michniak BB
Int J Pharm; 2003 Oct; 264(1-2):73-83. PubMed ID: 12972337
[TBL] [Abstract][Full Text] [Related]
5. Enhancement of nortriptyline penetration through human epidermis: influence of chemical enhancers and iontophoresis.
Merino V; Micó-Albiñana T; Nácher A; Díez-Sales O; Herráez M; Merino-Sanjuán M
J Pharm Pharmacol; 2008 Apr; 60(4):415-20. PubMed ID: 18380912
[TBL] [Abstract][Full Text] [Related]
6. In vitro and in vivo evaluation of the transdermal iontophoretic delivery of sumatriptan succinate.
Patel SR; Zhong H; Sharma A; Kalia YN
Eur J Pharm Biopharm; 2007 May; 66(2):296-301. PubMed ID: 17182233
[TBL] [Abstract][Full Text] [Related]
7. Delivery of a classical antihypertensive agent through the skin by chemical enhancers and iontophoresis.
Nair A; Reddy C; Jacob S
Skin Res Technol; 2009 May; 15(2):187-94. PubMed ID: 19622129
[TBL] [Abstract][Full Text] [Related]
8. Effect of iontophoresis and penetration enhancers on transdermal absorption of metopimazine.
Bounoure F; Lahiani Skiba M; Besnard M; Arnaud P; Mallet E; Skiba M
J Dermatol Sci; 2008 Dec; 52(3):170-7. PubMed ID: 18678472
[TBL] [Abstract][Full Text] [Related]
9. Combined strategies for enhancing the transdermal absorption of midazolam through human skin.
Balaguer-Fernández C; Femenía-Font A; Muedra V; Merino V; López-Castellano A
J Pharm Pharmacol; 2010 Sep; 62(9):1096-102. PubMed ID: 20796187
[TBL] [Abstract][Full Text] [Related]
10. Effect of permeation enhancers on the iontophoretic transport of metoprolol tartrate and the drug retention in skin.
Nair A; Vyas H; Shah J; Kumar A
Drug Deliv; 2011 Jan; 18(1):19-25. PubMed ID: 20726811
[TBL] [Abstract][Full Text] [Related]
11. Non-invasive iontophoretic delivery of enzymatically active ribonuclease A (13.6 kDa) across intact porcine and human skins.
Dubey S; Kalia YN
J Control Release; 2010 Aug; 145(3):203-9. PubMed ID: 20423719
[TBL] [Abstract][Full Text] [Related]
12. Bioadhesive monolayer film for the in vitro transdermal delivery of sumatriptan.
Femenía-Font A; Padula C; Marra F; Balaguer-Fernández C; Merino V; López-Castellano A; Nicoli S; Santi P
J Pharm Sci; 2006 Jul; 95(7):1561-9. PubMed ID: 16721755
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of percutaneous absorption of esculetin: effect of chemical enhancers.
del Rio Sancho S; Serna Jiménez CE; Calatayud Pascual MA; Balaguer Fernández C; Femenía Font A; Castillo García E; Merino V; López Castellano A
Planta Med; 2013 Jan; 79(2):131-6. PubMed ID: 23250808
[TBL] [Abstract][Full Text] [Related]
14. Development and evaluation of occlusive systems employing polyvinyl alcohol for transdermal delivery of sumatriptan succinate.
Balaguer-Fernández C; Padula C; Femenía-Font A; Merino V; Santi P; López-Castellano A
Drug Deliv; 2010 Feb; 17(2):83-91. PubMed ID: 20067437
[TBL] [Abstract][Full Text] [Related]
15. Limonene GP1/PG organogel as a vehicle in transdermal delivery of haloperidol.
Lim PF; Liu XY; Kang L; Ho PC; Chan YW; Chan SY
Int J Pharm; 2006 Mar; 311(1-2):157-64. PubMed ID: 16451823
[TBL] [Abstract][Full Text] [Related]
16. In vitro transdermal iontophoretic delivery of penbutolol sulfate.
Ita KB; Banga AK
Drug Deliv; 2009 Jan; 16(1):11-4. PubMed ID: 19555303
[TBL] [Abstract][Full Text] [Related]
17. Using transdermal iontophoresis to increase granisetron delivery across skin in vitro and in vivo: effect of experimental conditions and a comparison with other enhancement strategies.
Cázares-Delgadillo J; Ganem-Rondero A; Quintanar-Guerrero D; López-Castellano AC; Merino V; Kalia YN
Eur J Pharm Sci; 2010 Mar; 39(5):387-93. PubMed ID: 20096354
[TBL] [Abstract][Full Text] [Related]
18. A combined approach of chemical enhancers and sonophoresis for the transdermal delivery of tizanidine hydrochloride.
Mutalik S; Parekh HS; Davies NM; Udupa N
Drug Deliv; 2009 Feb; 16(2):82-91. PubMed ID: 19267299
[TBL] [Abstract][Full Text] [Related]
19. [Transdermal iontophoresis of insulin: effect of penetration enhancers on blood glucose level in diabetic rats].
Hao JS; Zheng JM; Yang WZ
Yao Xue Xue Bao; 1995; 30(10):776-80. PubMed ID: 8701733
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of constant current alternating current iontophoresis for transdermal drug delivery.
Yan G; Li SK; Higuchi WI
J Control Release; 2005 Dec; 110(1):141-50. PubMed ID: 16289410
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
